gene

RAN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about RAN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

155Connections
30Hypotheses
0Analyses
50Outgoing
50Incoming
15Experiments
0Debates

Summary

RAN is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, activates. Associated with Aging, Als, Amyotrophic Lateral Sclerosis. Connected to 73 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolRAN
Chromosome12q24.1
Amino Acids216 aa
Exons8
PathwaysEpigenetic, Notch, Circadian Rhythm, Tumor Microenvironment, Lipid Metabolism
GeneCardsRAN
Human Protein AtlasRAN
2019Partnership with Anthem (now Elevance Health) to deploy AI platform[@anthem]
2020Launch of virtual care services in response to COVID-19 pandemic
2021Acquisition of Hydrogen Health and Livongo assets
2022Workforce reduction of approximately 30%
2023Transition to profitability focus
2024Continued expansion of primary care services
Associated DiseasesAging, Als, Amyotrophic Lateral Sclerosis, Ataxia, Dementia, frontotemporal dementia
Known Drugs/Compoundsmetformin, rapamycin
InteractionsActin, Akt, AKT, ALS, AMPK, AMYOTROPHIC LATERAL SCLEROSIS
KG Connections155 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (9)

Knowledge base pages for this entity

Canonical Page

K Health

company · 2920 words

RAN Translation in Neurodegeneration

mechanism · 2989 words

RAN Gene

gene · 2633 words

RAN GTPase Protein

protein · 1164 words

ZRANB3 — Zinc Finger RanBP2-Type Containing 3

gene · 1063 words

RANK (TNFRSF11A)

gene · 723 words

Pathway Diagram

graph TD
    RAN["RAN"]
    Als{"Als"}
    RAN -->|"associated with"| Als
    Ms{"Ms"}
    RAN -->|"interacts with"| Ms
    Amyotrophic_Lateral_Sclerosis{"Amyotrophic Lateral Sclerosis"}
    RAN -->|"interacts with"| Amyotrophic_Lateral_Sclerosis
    Dementia{"Dementia"}
    RAN -->|"associated with"| Dementia
    Ataxia{"Ataxia"}
    RAN -->|"associated with"| Ataxia
    Huntington{"Huntington"}
    RAN -->|"associated with"| Huntington
    RAN -->|"associated with"| Ms
    RAN -->|"associated with"| Amyotrophic_Lateral_Sclerosis
    Inflammation{"Inflammation"}
    RAN -->|"inhibits"| Inflammation
    RAN -->|"regulates"| Als
    Neuroinflammation{"Neuroinflammation"}
    RAN -->|"inhibits"| Neuroinflammation
    RAN -->|"inhibits"| Amyotrophic_Lateral_Sclerosis
    C9ORF72["C9ORF72"]
    C9ORF72 -->|"interacts with"| RAN
    C9ORF72 -->|"associated with"| RAN
    P62["P62"]
    P62 -->|"inhibits"| RAN
    NOTCH3["NOTCH3"]
    NOTCH3 -->|"associated with"| RAN
    EIF2A["EIF2A"]
    EIF2A -->|"inhibits"| RAN
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    NEURODEGENERATIVE_DISEASES -->|"associated with"| RAN
    EIF2A -->|"activates"| RAN
    ATG["ATG"]
    ATG -->|"associated with"| RAN
    FTLD["FTLD"]
    FTLD -->|"contributes to"| RAN
    NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
    NEURODEGENERATIVE_DISORDERS -->|"associated with"| RAN
    style RAN fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (102)

TargetRelationTypeStr
Amyotrophic Lateral Sclerosisassociated_withdisease0.75
Alsassociated_withdisease0.75
ATGassociated_withgene0.70
AMYOTROPHIC LATERAL SCLEROSISassociated_withgene0.70
RNAregulatesgene0.70

Incoming (53)

SourceRelationTypeStr
C9ORF72associated_withgene0.70
ATGassociated_withgene0.70
LC3activatesgene0.60
C9ORF72therapeutic_targetgene0.60
CNBPassociated_withgene0.60

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop transcranial focused ultrasound with 40Hz gamma 1.000 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Dependent Microglial Senescence Transition 0.950 neurodegeneration Gene expression changes in aging mouse b
Closed-loop transcranial focused ultrasound targeting EC-II 0.948 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.922 Alzheimer's disease Circuit-level neural dynamics in neurode
HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM 0.919 neurodegeneration How do different microglial subtypes (DA
Closed-loop transcranial focused ultrasound to restore hippo 0.912 Alzheimer's disease Circuit-level neural dynamics in neurode
CSF1R Inhibition-Mediated Microglial Replacement as a State 0.898 neurodegeneration How do different microglial subtypes (DA
Closed-loop tACS targeting EC-II SST interneurons to block t 0.896 Alzheimer's disease Circuit-level neural dynamics in neurode
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.887 neurodegeneration How does APOE4's beneficial immune funct
Transcriptional Autophagy-Lysosome Coupling 0.882 neurodegeneration Autophagy-lysosome pathway convergence a
Optimized Temporal Window for Metabolic Boosting Therapy Det 0.879 neurodegeneration How do different microglial subtypes (DA
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl 0.869 neuroscience Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.858 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima 0.858 neurodegeneration How do different microglial subtypes (DA
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.857 Alzheimer's disease Circuit-level neural dynamics in neurode
miR-155/Interferon-gamma Feedback Loop as a Reversible Molec 0.843 neurodegeneration How do different microglial subtypes (DA
H6: Aberrant eIF2α Phosphorylation Creates Stalled Translati 0.834 neurodegeneration How do pathological stress granules tran
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Beta-frequency entrainment therapy targeting PV interneuron- 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Glymphatic-Mediated Tau Clearance Dysfunction 0.821 neuroscience Circuit-level neural dynamics in neurode
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular 0.812 neuroscience Circuit-level neural dynamics in neurode
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.811 neurodegeneration What are the cell-type-specific transcri
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl 0.806 neuroinflammation How do oligodendrocytes initiate neuroin
pH-Sensitive Bispecific Antibody Targeting Transferrin Recep 0.800 neurodegeneration Blood-brain barrier antibody transport m
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.797 Alzheimer's disease Circuit-level neural dynamics in neurode
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign 0.792 neuroscience Circuit-level neural dynamics in neurode
Closed-loop transcranial alternating current stimulation to 0.785 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-mediated microglial tau clearance enhancement 0.780 neurodegeneration Tau propagation mechanisms and therapeut
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic 0.780 neurodegeneration What is the therapeutic window between t

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (15)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn clinical Alzheimer's disease and relate 0.950 0.00 human patients proposed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) in_progress N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
Autophagy Enhancement Drug Screening for Neurodegeneration clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Macroautophagy Dysfunction in PD - Experiment Design clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Validate Mitochondria-Lysosome Contact Site Dysfunction in PD validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val validation Neurodegeneration 0.400 0.50 human proposed $3,000,000
MLCS Quantification in Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Presymptomatic GRN Carrier Intervention Timing — Biomarker-Guided Ther clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu validation Neurodegeneration 0.400 0.50 human proposed $2,730,000
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.200 0.00 Mouse (5xFAD/TREM2-/-) in_progress N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798] Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang Cell Mol Gastroenterol Hepatol 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466] Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji J Ethnopharmacol 2022 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] Wang Y, An H, Liu T, Qin C, Sesaki H, Gu Cell Rep 2019 1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] Song X, Zhu S, Chen P, Hou W, Wen Q, Liu Curr Biol 2018 1
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] Ulland TK, Song WM, Huang SC, Ulrich JD, Cell 2017 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664] Cid-Díaz T, Santos-Zas I, González-Sánch J Cachexia Sarcopenia Muscle 2017 1
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042] ["Lyu G", "Li D"] CNS & neurological disorders d 2026 0
Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793] ["Wang R", "Feng Y", "Zhou Z", "Jiang J" Frontiers in aging neuroscienc 2026 0
Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182] ["Puerta R", "Garc\u00eda-Gonz\u00e1lez medRxiv : the preprint server 2026 0
PTEN loss drives B7H3 upregulation via the mTORC2/FOXO/c-Myc axis to promote tum [PMID:41920736] Wang Z, Jin N, Li X, Ma X, Feng Y, Yin K Cell reports 2026 0
Mammalian lipophagy: process and function. [PMID:41681129] Zhao R, Dai E, Kang R, Liu J, Klionsky D Autophagy 2026 0
TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiqu [PMID:41921828] ["Xin Y", "Sun Y", "Pan E", "Li M", "Che Free radical biology & medicin 2026 0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] Tsai AP, Martin AK, Mi A, Yeh AE, Ramire Molecular neurodegeneration 2026 0
Combining network pharmacology and multi-omics reveals the role of Shengdihuang- [PMID:41655545] Cao X, Shang Y, Qu M, Kang Q, Xu Y et al Phytomedicine 2026 0
Comparative transcriptomics of adherent and suspension chicken fibroblast cell l [PMID:41763754] Contreras EJ, Nagarajan A, Bromberg BH, Food Res Int 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning RAN in their description or question text

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.912 · Alzheimer's disease · 2026-04-12

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholec

CSF1R Inhibition-Mediated Microglial Replacement as a State Transition Reset

Score: 0.898 · neurodegeneration · 2026-04-16

## Mechanistic Overview CSF1R Inhibition-Mediated Microglial Replacement as a State Transition Reset starts from the cla

Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and r

Score: 0.896 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to A

Score: 0.887 · neurodegeneration · 2026-04-14

## Mechanistic Overview H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

Transcriptional Autophagy-Lysosome Coupling

Score: 0.882 · neurodegeneration · 2026-04-02

## Mechanistic Overview Transcriptional Autophagy-Lysosome Coupling starts from the claim that modulating FOXO1 within t

Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of M

Score: 0.879 · neurodegeneration · 2026-04-16

## Mechanistic Overview Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

Score: 0.869 · neuroscience · 2026-04-12

## Mechanistic Overview GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance starts from the claim that m

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.858 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Faile

Score: 0.858 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and bl

Score: 0.857 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat

miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Prot

Score: 0.843 · neurodegeneration · 2026-04-16

## Mechanistic Overview miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Microglia

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

Score: 0.834 · neurodegeneration · 2026-04-22

## Mechanistic Overview H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State starts from the claim that

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.827 · Alzheimer's disease · 2026-04-16

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST inter

Score: 0.827 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to resto

Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling f

Score: 0.827 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance